Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ticona was a global leader in the production of high-performance engineering polymers and operated as the technical polymers business of Celanese Corporation. The company was a critical supplier to the healthcare industry, providing medical-grade plastics such as Hostaform acetal copolymer (POM) and GUR ultra-high molecular weight polyethylene (UHMWPE) for use in drug delivery devices, orthopedic implants, and surgical instruments. In 2013, Celanese integrated the Ticona brand into its core corporate identity to unify its global operations. Despite the rebranding, the legacy Ticona product lines remain industry standards for medical device engineering and pharmaceutical packaging applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ticona.